Food intake was measured at 1, 2, 4, 5 and 24 h post-transfer to the HFD
Patients often present with bloating, abdominal discomfort, irregular bowel habits, and IBS-like symptoms that havent responded to standard GI treatment
2023;46(Suppl
The first component, tirzepatide, is a dual GIP and GLP-1 receptor agonist that reduces appetite, slows gastric emptying, and improves insulin sensitivity
Ascorbate, dithiothreitol and TCEP all reduce copper(II) to copper(I), and the donor arrangement in this tripeptide stabilizes the divalent ion specifically
They may suggest adjusting the dose, slowing the titration schedule, or prescribing anti-nausea medication to help you stay on track with treatment